t rate of 8% and terminal growth of 3% achieves a pri e target of $20.00. Key Assumptions Base Case Bull Case Bear Case Primary Research Type I Adoptoix 51% 75% 7?/ii Mae than 25 Type 1 diabetics DXCM Market Share: 50% 70% 25% Former enploye of Deacon & Metratic Annual Pricing: Flat 5% -3